|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prevalence,comorbidity and impact of irritable bowel syndrome in Norway显示文摘 | Vandvik PO Lydersen S Farup PG | 2006 | Scand J Gastroenterol2006，41，6： | 1 |
| 2 | Perceived food intolerance in subjects with irritable bowel syndrome-etiology,prevalence and consequences显示文摘 | Monsbakken KW Vandvik PO Farup PG | 2006 | Eur J Clin Nutr2006，60，5： | 1 |
| 3 | Perceived food intolerance in subjects with irritable bowel syndrome-?etiology, prevalence and consequences 显示文摘 | Monsbakken KW Vandvik PO Farup PC | 2006 | Eur J Clin Nutr2006，60，5： | 1 |
| 4 | Probioties for the prevention of pediatric antibiotic-associated diarrhea显示文摘 | Johnston BC Goldenberg JZ Vandvik PO | 2011 | Cochrane Database Syst Rev2011，9，00： | 1 |
| 5 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea 显示文摘 | Johnston BC Goldenberg JZ Vandvik PO | 2011 | Cochrane Database Syst Rev2011，11，00： | 1 |
| 6 | Primary and seconda- ry prevention of cardiovascular disease 显示文摘 | Vandvik PO Lincoff AM Gore JM | 2012 | CHEST2012，141，2： | 1 |
| 7 | Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications 显示文摘 | Vandvik PO Wilhelmsen I Ihlebaek C | 2004 | Aliment Pharmacol Ther2004，20，10： | 1 |
| 8 | Perceived food intolerance in subjects with irritable bowel syndrome-etiology,prevalence and consequences显示文摘 | Monsbakken KW Vandvik PO Farup PG | 2006 | Eur J Clin Nutr2006，60，5： | 1 |
| 9 | Prevalence, comorbidity and impact of irritable bowel syndrome in Norway显示文摘 | Vandvik PO Lydersen S Farup PG | 2006 | Scand J Gas- troentero12006，41，6： | 1 |
| 10 | Prevalence, comorbidity and impact of irritable bowel syndrome in Norway 显示文摘 | Vandvik PO Lydersen S Farup PG | 2006 | Scand J Gastroenterol2006，41，6： | 1 |
| 11 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea 显示文摘 | Johnston BC Goldenberg JZ Vandvik PO | 2017 | Cochrane Database of Systematic Reviews2017，18，00： | 1 |
| 12 | Primary and secondary prevention of cardiovascular disease;antithrombotic therapy and prevention of thrombosis, 9th ed:American College of Chest Physicians evidence-based clinical practice guidelines显示文摘 | Vandvik PO Lincoff AM Gore JM | 2012 | Chest2012，141，2： | 1 |
| 13 | Prevalence,comorbidity and impact of irritable bowel syndrome in Norway显示文摘 | Vandvik PO Lydersen S Farup PG | 2006 | Scand J Gastroenterol2006，41，6： | 1 |
| 14 | Primary and secondary prevention of cardiovascular disease : antihrombotic therapy and prevention of thrombosis, 9th ed : American College of Chest Physicians evidence - based clinical practice guidelines ( ACCP - 9 ) 显示文摘 | Vandvik PO Lincoff AM Gore JM | 2012 | Chest2012，141，2： | 1 |
| 15 | Prevalence, comorbidity and impact of irritable bowel syndrome in Norway显示文摘 | Vandvik PO Lydersen S Farup PG | 2006 | Seand J Gastro enterol2006，41，： | 1 |
| 16 | Perceived food intolerance in subjects with irritable bowel syndrome-Etiology,prevalence and consequences显示文摘 | Monsbakken KW Vandvik PO Farup PG | 2006 | European Journal of Clinical Nutrition2006，60，5： | 1 |
| 17 | Prevalence,comorbidity and impact of irritable bowel syndrome in Norway显示文摘 | Vandvik PO Lydersen S Farup PG | 2006 | Scand J Gastroenterol2006，41，6： | 1 |
| 18 | Prevalence, comorbidity and impact of irritable bowel syndrome in Norway 显示文摘 | Vandvik PO Lydersen S Famp PG | 2006 | Scand J Gastroentero12006，41，6： | 1 |
| 19 | Primary and secondary prevention of cardiovascular disease:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘 | Vandvik PO Lincoff AM Gore JM | | 0，，2： | 1 |
| 20 | Primary and secondary prevention of cardiovascular disease: Antithrombotie Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physi- cians Evidence-Based Clinical Practice Guidelines 显示文摘 | Vandvik PO Lincoff AM Gore JM | 2012 | Chest2012，141，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员